EP3518962
SEBELIPASE ALFA FOR USE IN LIVER FIBROSIS AND TREATING LYSOSOMAL ACID LIPASE DEFICIENCY IN PATIENTS BASED ON ISHAK FIBROSIS STAGE
:
EP einkaleyfi: Þýðing ekki lögð inn:
28.9.2017:
9.6.2021:
17791485.0
:
27.9.2037
:
SEBELIPASE ALFA FOR USE IN LIVER FIBROSIS AND TREATING LYSOSOMAL ACID LIPASE DEFICIENCY IN PATIENTS BASED ON ISHAK FIBROSIS STAGE
28.9.2017
9.6.2021
:
Alexion Pharmaceuticals, Inc.:
121 Seaport Boulevard, Boston, MA 02210, US
:
QUINN, Anthony:
Gloucester MA 01930, US
:
GOODMAN, Zachary:
Falls Church VA 22042, US
:
BURTON, Barbara:
Chicago IL 60611, US
:
RANKIN, Andrew:
Boston MA 02110, US
:
FRIEDMAN, Mark:
Newton MA 02461, US
:
SONI, Paresh:
Mystic CT 06355, US
:
201662402183 P:
30.9.2016:
US
:
201662420233 P:
10.11.2016:
US
:
201762456511 P:
8.2.2017:
US
:
US2017053961:
28.9.2017
:
A61K 38/46, A61P 1/16, A61P 3/00